The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOPP.L Regulatory News (OPP)

  • There is currently no data for OPP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Suspension from Trading

26 Apr 2022 07:00

RNS Number : 2818J
Origo Partners PLC
26 April 2022
 

 

26 April 2022

Origo Partners Plc ("Origo" or "the Company")

Cash distribution, Suspension From Trading, and Delisting

 

On 11 April 2022, Origo was informed that Origo's Nominated Advisor, Arden Partners Plc., was being acquired by a third party and as a consequence would no longer be eligible to act as a Nominated Advisor to AIM companies, including Origo, after 28 April 2022. The implications of this are that as of 28 April 2022 Origo's ordinary and redeemable preference shares ("shares") will be suspended from trading on the AIM market unless Origo appoints another Nominated Advisor.

 

The Origo board has investigated and considered the implications of retaining another Nominated Advisor in light of where the Company stands today, in particular that it has fulfilled its announced objectives of monetizing all legacy investments that are saleable and returning the proceeds to shareholders. In light of the Company's progress in fulfilling these objectives, the Board has determined that the financial implications of appointing a new Nominated Advisor are not in the best interests of the Company. As a consequence, as at 7.30am on 28 April 2022, Origo's shares will be suspended from trading on AIM and as at 30 May 2022 the admission of Origo's shares to AIM will be cancelled.

 

In accordance with Origo's previously announced strategy and ahead of 30 May 2022, Origo will announce a payout of all distributable cash and will make that payment as soon as practicable thereafter. Pursuant to the Company's Articles of Association, eighty per cent of any distributable amount will be paid to the holders of the Company's redeemable preference shares and twenty per cent of any distributable amount will be paid to holders of the Company's ordinary shares. Dependent on possible developments concerning Origo's Celadon investment, this will likely be Origo's final distribution.

 

Following suspension and AIM cancellation, Origo will continue to report to shareholders through the RNS service as well as to post information on its website: www.origopartners.com . Although the shares will remain freely transferable post 27 April 2022, once the shares are suspended from trading there will be no formal mechanism for trading shares. As a consequence, the shares' liquidity and marketability will be significantly reduced and this may affect the value of those shares. In order to enable the transferability of Origo shares following suspension and delisting, Origo's administrator, FIM Capital Limited will provide a Matched Bargain Facility that will enable investors to transact in Origo shares. Mr. Philip Scales who is both a director of Origo and a director of FIM Capital Limited will assume oversight of the Matched Bargain Facility and details of that facility will be forthcoming.

 

 

 

Further announcements will be made in due course.

 

Ends

For further information about Origo please visit www.origopartners.com or contact: 

 

Origo Partners plc

John Chapman

Chairman

 55 Street

Douglas

Isle of Man IM1 1LA

Nominated Adviser and Broker

Arden Partners plc

Richard Johnson

 

 +44 (0)20 7614 5900

 

The information contained within this announcement is deemed by the Company to constitute inside information as defined in Article 7 of the Market Abuse Regulation No. 596/2014 ("MAR") which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. With the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUVARRURUSUUR
Date   Source Headline
30th May 20227:00 amRNSCancellation - Origo Partners Plc
27th May 20226:00 pmRNSOrigo Partners
28th Apr 20227:30 amRNSSuspension – Origo Partners plc
26th Apr 20227:00 amRNSSuspension from Trading
7th Mar 20227:00 amRNSAsset Sale Update
2nd Feb 20227:00 amRNSReturn of Capital and Asset Sale
27th Jan 20223:16 pmRNSAsset Sale
24th Dec 202110:46 amRNSResult of AGM
6th Dec 20213:34 pmRNSNotice of AGM
3rd Dec 20217:00 amRNSInvestment Update
22nd Sep 20217:00 amRNSHalf-year Report
28th Jun 20217:00 amRNSAnnual Financial Report
4th Jun 20217:00 amRNSSale of Shares in Gobi Coal & Energy Ltd
14th May 202111:18 amRNSHolding(s) in Company
9th Mar 202112:20 pmRNSHolding(s) in Company
8th Mar 20217:00 amRNSStatement re share price movement
24th Feb 20214:27 pmRNSHolding(s) in Company
23rd Feb 20219:53 amRNSHolding(s) in Company
27th Jan 20218:38 amRNSUpdate re Website
22nd Jan 202110:03 amRNSUpdate re Remaining Assets
24th Dec 202011:20 amRNSResult of AGM
24th Dec 202010:14 amRNSHolding(s) in Company
24th Dec 20209:51 amRNSHolding(s) in Company
17th Dec 202012:38 pmRNSHolding(s) in Company
30th Nov 20204:30 pmRNSNotice of AGM
28th Sep 20207:00 amRNSHalf-year Report
23rd Sep 20207:09 amRNSPrice Monitoring Extension
23rd Sep 20207:02 amRNSSecond Price Monitoring Extn
22nd Sep 20202:06 pmRNSSecond Price Monitoring Extn
22nd Sep 20202:01 pmRNSPrice Monitoring Extension
30th Jun 20207:00 amRNSAnnual Financial Report
12th Jun 20207:00 amRNSInvestment update
20th May 202011:00 amRNSHolding(s) in Company
7th May 20207:00 amRNSUpdate RE: Liquidation Plans
29th Apr 20202:06 pmRNSSecond Price Monitoring Extn
29th Apr 20202:02 pmRNSPrice Monitoring Extension
17th Mar 202012:12 pmRNSChange of Registered Office & Update on Website
12th Mar 20203:32 pmRNSWebsite
4th Feb 20207:00 amRNSInvestment Update
24th Dec 20197:00 amRNSInvestors update
11th Nov 201911:33 amRNSHolding(s) in Company
30th Oct 20194:16 pmRNSResult of AGM
23rd Oct 201910:41 amRNSHolding(s) in Company
23rd Oct 201910:39 amRNSHolding(s) in Company
4th Oct 20194:23 pmRNSNotice of AGM
27th Sep 20194:25 pmRNSReplacement Capital Distribution
27th Sep 201911:05 amRNSReplacement Interim Unaudited Financial Statements
27th Sep 20197:05 amRNSCapital Distribution
27th Sep 20197:00 amRNSInterim Unaudited Financial Statements
28th Jun 20194:15 pmRNSPosting of Annual Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.